The anti-apoptotic effect of Dex remained the same even when Dex was added to cells 24 hours after the addition of TKI, indicating that a brief exposure to Dex may still reduce the efficacy of EGFR-TKIs in the treatment of NSCLC cells (Figure 1E, 1F). Here, EGFR is linked to non-small cell lung carcinoma.